Titre:
  • Integrated Molecular and Immune Phenotype of HER2-Positive Breast Cancer and Response to Neoadjuvant Therapy: A NeoALTTO Exploratory Analysis
Auteur:Pizzamiglio, Sara; Ciniselli, Chiara Maura; Triulzi, Tiziana; Gargiuli, Chiara; Cecco, Loris De; de Azambuja, Evandro; Fumagalli, Debora; Sotiriou, Christos; Harbeck, Nadia; Izquierdo, Miguel; Nuciforo, Paolo Giovanni; Huober, J.; Cappelletti, Vera; Cinieri, Saverio; Piccart-Gebhart, Martine; Daidone, Maria Grazia; Pruneri, Giancarlo; Colombo, Mario Paolo; Tagliabue, Elda; Verderio, Paolo; Cosimo, Serena Di
Informations sur la publication:Clinical cancer research, 27, 23, page (6307-6313)
Statut de publication:Publié, 2021-12-01
Sujet CREF:Cancérologie
MeSH keywords:Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
Breast Neoplasms -- drug therapy -- genetics -- pathology
Female
Humans
Neoadjuvant Therapy
Neoplasm Recurrence, Local -- drug therapy
Phenotype
Receptor, ErbB-2 -- genetics -- therapeutic use
Trastuzumab -- therapeutic use
Treatment Outcome
Note générale:SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:1078-0432
info:doi/10.1158/1078-0432.CCR-21-1600
info:pii/1078-0432.CCR-21-1600
info:scp/85120475656
info:pmid/34548320